Broadfoot Jill Marie 4
4 · aTYR PHARMA INC · Filed Jan 9, 2024
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Broadfoot Jill Marie
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-01-05+150,000→ 150,000 totalExercise: $1.50Exp: 2034-01-05→ Common Stock (150,000 underlying)
Holdings
- 18,661
Common Stock
Footnotes (2)
- [F1]Includes 1,025 shares acquired on May 15, 2023 and 2,176 shares acquired on November 15, 2023 under the Company's 2015 Employee Purchase Plan.
- [F2]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 5, 2024, such that this option will be fully exercisable on January 5, 2028. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.